COMMUNIQUÉS West-GlobeNewswire

Kane Biotech to Present at The MicroCap Conference in Toronto
14/06/2018
Conference Held June 21 Featuring Attractive Companies Across All Sectors WINNIPEG, Manitoba, June 14, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is [...]
Avinger Announces First Patients Enrolled in Post-Market Study Comparing Pantheris OCT Imaging to Intravascular Ultrasound
14/06/2018
SCAN Clinical Trial Results Intended to Support CPT Code Application for Incremental Diagnostic Reimbursement REDWOOD CITY, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of [...]
OpGen Modifies Terms of Debt with Merck Global Health Innovation Fund
14/06/2018
GAITHERSBERG, Md., June 14, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it has negotiated modifications related to its $1,000,000 Second Amended and Restated Senior Secured Promissory Note ( [...]
Clinical Genomics Pathology Inc. receives licensure from State of California Department of Public Health
14/06/2018
BRIDGEWATER, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer testing and solutions, is pleased to announce that its CLIA licensed and CAP accredited New Jersey [...]
Agritek Holdings, Inc. Announces Permit Approvals For San Juan, Puerto Rico 15,000 Sq. Ft. Cultivation And Processing Facility As Colorado Hemp Farm Moves Toward Production
14/06/2018
LOS ANGELES, CA, June 14, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]
Vilacto Bio’s Vilact Skin Cream Wins Award at Las Vegas ECRM Skin, Bath, Cosmetics & Natural Beauty EPPS
14/06/2018
COPENHAGEN, Denmark, June 14, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc.’s (OTCQB:VIBI) Vilact skin cream won the buyers choice award at the recent ECRM Skin, Bath, Cosmetics & Natural Beauty EPPS (efficient program [...]
ContraVir Pharmaceuticals Announces the Approval of the IND and Initiation of the Clinical Development Program of CRV431 in the United States
14/06/2018
EDISON, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures
14/06/2018
SAINT LAURENT, Quebec, June 14, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “ Company ” or “ IntelGenx ”) announces that it intends to issue 307,070 common shares of the [...]
Evolus to Participate in Two Upcoming Investor Conferences
14/06/2018
IRVINE, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (“Evolus”) (NASDAQ:EOLS), a premiere aesthetics company, announced today that members of management will be participating in two upcoming investor [...]
Foamix Pharmaceuticals to Participate in the Cantor Dermatology & Aesthetics Summit
14/06/2018
REHOVOT, Israel and BRIDGEWATER, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary [...]
Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st
14/06/2018
WALTHAM, Mass., June 14, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
ContraVir Pharmaceuticals Announces the Approval of the IND and Initiation of the Clinical Development Program of CRV431 in the United States
14/06/2018
EDISON, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
AIT Therapeutics Reports Financial Results for Three Months Ended March 31, 2018
14/06/2018
Announced positive top-line data for Nitric Oxide in Bronchiolitis (NO-BRO) Pilot Study Presented data from its inhaled Nitric Oxide study in patients infected with mycobacterium abscessus complex (MABSC) at the 2018 [...]
Progressive Care Inc. Continues to See Strong Prescription Numbers and Overall Revenue in May 2018
14/06/2018
MIAMI, June 14, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in both revenue and number of [...]
Natus Medical Board Announces Commitment to Governance Enhancements
14/06/2018
PLEASANTON, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- The Board of Directors of Natus Medical Incorporated today announced that it commits to taking certain actions to strengthen the Company's corporate governance based [...]
Evelo Biosciences to Present at the JMP Securities 2018 Life Sciences Conference
14/06/2018
CAMBRIDGE, Mass., June 14, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company pioneering monoclonal microbials designed to act on the gut-body network for the [...]
K2M Group Holdings, Inc. Announces Pricing of Private Offering of $65.0 Million Aggregate Principal Amount of 3.00% Convertible Senior Notes due 2025
14/06/2018
LEESBURG, Va., June 14, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq:KTWO) (“K2M”) today announced the pricing of a private offering of $65.0 million aggregate principal amount of 3.00% Convertible Senior [...]
Arsanis Out-Licenses Preclinical Stage Klebsiella pneumoniae Monoclonal Antibodies from ASN300 Program
14/06/2018
Second recent transaction with Bravos Biosciences consolidates development of Arsanis gram-negative mAb candidates with global experts in anti-infective drug development WALTHAM, Mass. and VIENNA, Austria, June 14, 2018 [...]
Retrophin Announces Expansion of Intellectual Property Estate for Sparsentan with Newly Issued U.S. Patent
14/06/2018
SAN DIEGO, June 14, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ:RTRX) today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent covering the Company’s product candidate [...]

Pages